Fundraising Fox

Trialtus Bioscience

Birmingham, US · Founded 2017 · Delaware LLC

TriAltus Bioscience manufactures ultra-pure recombinant proteins and specialty enzymes using its proprietary CLīM purification technology, which produces high-performance proteins in a single step. It supplies reagents to research teams working in drug discovery, diagnostics, synthetic biology, and CRISPR workflows.

BiotechDeep Tech

Founders & leadership

RS
Robert ShufflebargerChief Executive Officer of the Issuer

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 1 round · 2018

▶$1.6MraisedApr 2019 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert ShufflebargerExecutive Officer
Offering amount
$2M
Amount sold
$1.6M
Minimum investment
$25K
First sale
May 2018
Incorporated
Limited Liability Company, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$256.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Trialtus Bioscience do?
TriAltus Bioscience manufactures ultra-pure recombinant proteins and specialty enzymes using its proprietary CLīM purification technology, which produces high-performance proteins in a single step. It supplies reagents to research teams working in drug discovery, diagnostics, synthetic biology, and CRISPR workflows.
How much funding has Trialtus Bioscience raised?
Trialtus Bioscience has disclosed $1.6M raised across 1 round.
Where is Trialtus Bioscience headquartered?
Trialtus Bioscience is headquartered in Birmingham, US.